Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

The return of trachoma in partially treated communities.

Yang JL, Lietman TM.

Arch Ophthalmol. 2007 Jul;125(7):989-91. No abstract available.

PMID:
17620592
2.

Impact of annual targeted treatment on infectious trachoma and susceptibility to reinfection.

Atik B, Thanh TT, Luong VQ, Lagree S, Dean D.

JAMA. 2006 Sep 27;296(12):1488-97. Erratum in: JAMA. 2007 Feb 14;297(6):590.

PMID:
17003397
3.

Complete elimination is a difficult goal for trachoma programs in severely affected communities.

Gill DA, Lakew T, Alemayehu W, Melese M, Zhou Z, House JI, Hong KC, Ray KJ, Gandhi N, Whitcher JP, Gaynor BD, Lietman TM.

Clin Infect Dis. 2008 Feb 15;46(4):564-6. doi: 10.1086/526777.

4.

Should trachoma be treated with antibiotics?

Dawson CR, Schachter J.

Lancet. 2002 Jan 19;359(9302):184-5. No abstract available.

PMID:
11812548
5.

Comparison of two azithromycin distribution strategies for controlling trachoma in Nepal.

Holm SO, Jha HC, Bhatta RC, Chaudhary JS, Thapa BB, Davis D, Pokhrel RP, Yinghui M, Zegans M, Schachter J, Frick KD, Tapert L, Lietman TM.

Bull World Health Organ. 2001;79(3):194-200. Epub 2003 Jul 7.

6.

Community treatment with azithromycin for trachoma is not associated with antibiotic resistance in Streptococcus pneumoniae at 1 year.

Gaynor BD, Holbrook KA, Whitcher JP, Holm SO, Jha HC, Chaudhary JS, Bhatta RC, Lietman T.

Br J Ophthalmol. 2003 Feb;87(2):147-8.

7.

Evaluating the "A" component of the SAFE strategy.

Dean D, Atik B, Ton TK, Vu QL, Lagree S.

Lancet Infect Dis. 2007 Jan;7(1):2-3. No abstract available.

PMID:
17182334
8.

Slow resolution of clinically active trachoma following successful mass antibiotic treatments.

Keenan JD, Lakew T, Alemayehu W, Melese M, House JI, Acharya NR, Porco TC, Gaynor BD, Lietman TM.

Arch Ophthalmol. 2011 Apr;129(4):512-3. doi: 10.1001/archophthalmol.2011.46. No abstract available.

PMID:
21482879
9.

Distribution of azithromycin for the treatment of trachoma.

Taylor KI, Taylor HR.

Br J Ophthalmol. 1999 Feb;83(2):134-5. No abstract available.

10.

Effect of mass distribution of azithromycin for trachoma control on overall mortality in Ethiopian children: a randomized trial.

Porco TC, Gebre T, Ayele B, House J, Keenan J, Zhou Z, Hong KC, Stoller N, Ray KJ, Emerson P, Gaynor BD, Lietman TM.

JAMA. 2009 Sep 2;302(9):962-8. doi: 10.1001/jama.2009.1266.

PMID:
19724043
11.

Eliminating trachoma in areas with limited disease.

Gaynor BD, Miao Y, Cevallos V, Jha H, Chaudary JS, Bhatta R, Osaki-Holm S, Yi E, Schachter J, Whitcher JP, Lietman T.

Emerg Infect Dis. 2003 May;9(5):596-8.

12.

Azithromycin treatment levels inadequate for recommended trachoma control guidelines.

Kelaher M, Ferdinand AS, Taylor HR.

Med J Aust. 2011 Jan 17;194(2):102. No abstract available.

PMID:
21241228
13.

Associations between active trachoma and community intervention with Antibiotics, Facial cleanliness, and Environmental improvement (A,F,E).

Ngondi J, Matthews F, Reacher M, Baba S, Brayne C, Emerson P.

PLoS Negl Trop Dis. 2008 Apr 30;2(4):e229. doi: 10.1371/journal.pntd.0000229.

14.

Single-dose azithromycin in the treatment of trachoma. A randomized, controlled study.

Tabbara KF, Abu-el-Asrar A, al-Omar O, Choudhury AH, al-Faisal Z.

Ophthalmology. 1996 May;103(5):842-6.

PMID:
8637698
15.

Systemic antibiotics for communitywide trachoma control.

Sommer A.

Arch Ophthalmol. 2005 May;123(5):687-8. No abstract available.

PMID:
15883291
16.

Effect of azithromycin mass drug administration for trachoma on spleen rates in Gambian children.

Hart JD, Edwards T, Burr SE, Harding-Esch EM, Takaoka K, Holland MJ, Sillah A, Mabey DC, Bailey RL.

Trop Med Int Health. 2014 Feb;19(2):207-11. doi: 10.1111/tmi.12234. Epub 2014 Jan 17.

17.

Efficacy of oral azithromycin versus topical tetracycline in mass treatment of endemic trachoma.

Fraser-Hurt N, Bailey RL, Cousens S, Mabey D, Faal H, Mabey DC.

Bull World Health Organ. 2001;79(7):632-40.

18.

Adverse and beneficial secondary effects of mass treatment with azithromycin to eliminate blindness due to trachoma in Nepal.

Fry AM, Jha HC, Lietman TM, Chaudhary JS, Bhatta RC, Elliott J, Hyde T, Schuchat A, Gaynor B, Dowell SF.

Clin Infect Dis. 2002 Aug 15;35(4):395-402. Epub 2002 Jul 23.

19.

Elimination of active trachoma after two topical mass treatments with azithromycin 1.5% eye drops.

Amza A, Goldschmidt P, Einterz E, Huguet P, Olmiere C, Bensaid P, Bella-Assumpta L.

PLoS Negl Trop Dis. 2010 Nov 23;4(11):e895. doi: 10.1371/journal.pntd.0000895.

20.

When can antibiotic treatments for trachoma be discontinued? Graduating communities in three African countries.

Ray KJ, Lietman TM, Porco TC, Keenan JD, Bailey RL, Solomon AW, Burton MJ, Harding-Esch E, Holland MJ, Mabey D.

PLoS Negl Trop Dis. 2009 Jun 16;3(6):e458. doi: 10.1371/journal.pntd.0000458.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk